1111 related articles for article (PubMed ID: 27033198)
1. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
[TBL] [Abstract][Full Text] [Related]
6. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
8. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, antioxidants and neurodegenerative diseases.
Casetta I; Govoni V; Granieri E
Curr Pharm Des; 2005; 11(16):2033-52. PubMed ID: 15974957
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier.
Gilgun-Sherki Y; Melamed E; Offen D
Neuropharmacology; 2001 Jun; 40(8):959-75. PubMed ID: 11406187
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
[TBL] [Abstract][Full Text] [Related]
14. Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders.
Akanji MA; Rotimi DE; Elebiyo TC; Awakan OJ; Adeyemi OS
Oxid Med Cell Longev; 2021; 2021():9971885. PubMed ID: 34394839
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
16. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
17. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.
Milani P; Ambrosi G; Gammoh O; Blandini F; Cereda C
Oxid Med Cell Longev; 2013; 2013():836760. PubMed ID: 23983902
[TBL] [Abstract][Full Text] [Related]
18. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
19. Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.
Ullah R; Khan M; Shah SA; Saeed K; Kim MO
Nutrients; 2019 May; 11(6):. PubMed ID: 31141884
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
Prasad KN; Bondy SC
Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
